Cargando…
Asthma and prognosis of coronavirus disease 2019
It is well-known that asthma patients show compromised production of antiviral interferons and lower expression of ACE-2, most likely owing to ACE-2 expression is inversely correlated with type 2 (Th2: T helper 2) cytokine levels of asthmatics. However, COVID-19 patients with poor outcomes show earl...
Autor principal: | Özdemir, Öner |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
World Allergy Organization
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9151523/ https://www.ncbi.nlm.nih.gov/pubmed/35662874 http://dx.doi.org/10.1016/j.waojou.2022.100656 |
Ejemplares similares
-
Eosinophilic inflammation, coronavirus disease 2019, and asthma: Are inhaled corticosteroids the missing link?
por: Ramakrishnan, Sanjay, et al.
Publicado: (2021) -
What is the Determinant of 2019 Novel Coronavirus Prognosis in Children?
por: Yurttutan, Sadik
Publicado: (2000) -
Famotidine and Coronavirus Disease 2019
por: Freedberg, Daniel E., et al.
Publicado: (2021) -
Coronavirus Disease 2019 and Primary Antibody Deficiencies. Comment on Milota et al. Clinical Outcome of Coronavirus Disease 2019 in Patients with Primary Antibody Deficiencies. Pathogens 2023, 12, 109
por: Özdemir, Öner
Publicado: (2023) -
Famotidine and Mortality in Coronavirus Disease 2019
por: Sethia, Rahul, et al.
Publicado: (2021)